glp 1 pancreatitis GLP-1: Actions on Beta-cell Mass and Function GLP-1–Based Therapy for Diabetes: What

N Engl J Med 384(11):9891002 Karagiannis T, Malandris K, Avgerinos I et al (2024) Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials

BTK is an enzyme involved in the activation of B-cells, which are a type of white blood cell that plays a key role in the immune system

The heightened occurrences of nausea and vomiting incidents found in the Wegovy trial align with the theory that semaglutide causes an increased risk of gastroparesis, since Wegovy is more than double the dose at 2.4mg compared to Ozempics 1mg dose

This effect can lead to a reduction in overall caloric intake, making Ozempic a valuable component of a weight management strategy

According to GoodRx, most people need at least 6-12 weeks of consistent use to determine effectiveness

Prevalence and predictors of diabetes distress among adults with type 2 diabetes mellitus: a facility-based cross-sectional study of Bangladesh